Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ribavirin therapeutic drug monitoring: why, when and how?
Stanke-Labesque F, Loustaud-Ratti V, Babany G, Gagnieu MC, Marquet P; French Ribavirin Group OPTIRIB. Stanke-Labesque F, et al. Among authors: marquet p. Fundam Clin Pharmacol. 2010 Aug;24(4):401-6. doi: 10.1111/j.1472-8206.2009.00778.x. Epub 2009 Sep 24. Fundam Clin Pharmacol. 2010. PMID: 19788564 Review.
Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
Loichot C, Bentue-Ferrer D, Bernard N, Bonardet A, Boulieu R, Kergueris MF, Paintaud G, Peytavin G, Simon N, Marquet P; Therapeutic Drug Monitoring Group of the French Pharmacological Society. Loichot C, et al. Among authors: marquet p. Fundam Clin Pharmacol. 2006 Feb;20(1):91-6. doi: 10.1111/j.1472-8206.2005.00383.x. Fundam Clin Pharmacol. 2006. PMID: 16448399
Ribavirin in chronic hepatitis C: past and future.
Loustaud-Ratti V, Rousseau A, Marquet P, Denis F, Alain S. Loustaud-Ratti V, et al. Among authors: marquet p. Expert Rev Anti Infect Ther. 2009 Apr;7(3):249-53. doi: 10.1586/eri.09.5. Expert Rev Anti Infect Ther. 2009. PMID: 19344238 No abstract available.
Feasibility of ribavirin therapeutic drug monitoring in hepatitis C.
Sauvage FL, Stanke-Labesque F, Gagnieu MC, Jourdil JF, Babany G, Marquet P. Sauvage FL, et al. Among authors: marquet p. Ther Drug Monit. 2009 Jun;31(3):374-81. doi: 10.1097/FTD.0b013e3181a665e3. Ther Drug Monit. 2009. PMID: 19412142 Free PMC article.
564 results